51SHOULD WE CONSIDER FRAILTY WHEN TREATING ATRIAL FIBRILLATION?

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias?

Atrial fibrillation (AF) affects more than 5% of the U.S. population .65 years, and 10% of those .80 years of age, making it the most common arrhythmia requiring treatment. Efforts to treat with ablation or devices show promise, but to date, pharmacologic therapy represents the mainstay of AF treatment. The benefit of efforts to control the rhythm (as opposed to rate control with anticoagulatio...

متن کامل

Treating Atrial Fibrillation With Cryoballoon Technology.

Cryoballoon ablation has emerged as a novel tool to perform pulmonary vein isolation. The aim of this paper is to review the advantages, drawbacks as well as possible complications and clinical outcomes of this technology and to discuss some important technical issues.

متن کامل

Can we ablate permanent atrial fibrillation?

There is growing evidence of the benefit of ablation in the treatment of drug refractory atrial fibrillation.

متن کامل

Can we predict stroke in atrial fibrillation?

Stroke prevention with appropriate thromboprophylaxis still remains central to the management of atrial fibrillation (AF). Nonetheless, stroke risk in AF is not homogeneous, but despite stroke risk in AF being a continuum, prior stroke risk stratification schema have been used to 'artificially' categorise patients into low, moderate and high risk stroke strata, so that the patients at highest r...

متن کامل

Atrial Fibrillation Ablation - Are we ready?

Atrial fibrillation (AF) is the most common arrhythmia in day to day practice. It contributes to morbidity in the form of heart failure and stroke and increased overall and cardiovascular mortality1. Moreover, no treatment of AF to date has resulted in a lower overall death rate. Anti arrhythmic therapy for AF may also contribute to increased mortality in this subgroup2. Even though AFFIRM inve...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Age and Ageing

سال: 2019

ISSN: 0002-0729,1468-2834

DOI: 10.1093/ageing/afz056.01